P2Y12R antagonists, such as clopidogrel and ticagrelor, are currently in wide use for stroke and thrombosis, as are P2Y2R agonists for dry eye and A1R agonists for supraventricular tachycardia. This evidence concerns the gene P2RY12 and stroke disorder.